Mycosis fungoides with extracutaneous localization in the breast

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 1125-1130

  Jaspars, L H ^a   Bonnet, P ^a   Willemze, R ^a   Meijer, C J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; ARTICLE; CASE REPORT; CELL ADHESION; FEMALE; HUMAN; HUMAN TISSUE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL;

EID: 0029999821     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07957.x     Document Type: Article

References (20)

1. Barcos M. Mycosis fungoides. Diagnosis and pathogenesis. Am J Clin Pathol 1993; 99: 452-8.
2. Rappaport H, Thomas LB. Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 1974; 34: 1198-229.
3. Salhany KE, Cousar JB, Greer JP et al. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988; 132: 265-77.
4. Burgeson RE, Chiquet M, Deutzman R et al. A new nomenclature for laminins. Matrix Biol 1994; 14: 209-11.
5. Wayner EA, Gil SG, Murphy GF et al. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for α3β1 positive T lymphocytes. J Cell Biol 1993; 121: 1141-52.
6. Dustin ML, Singer KH, Tuck DT, Springer TA. Adhesion of T lymphoblasts to epithelial keratinocytes is regulated by interferon-γ and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 1988; 167: 1323-40.
7. Simonitsch I, Vole-Platzer B, Mosberger I, Radaszkiewicz T. Expression of monoclonal antibody HML-1 defined αEβ7 integrin in cutaneous T cell lymphoma. Am J Pathol 1994; 145: 1148-58.
8. Sperling M, Kaudewitz P, Braun-Falco O, Stein H. Reactivity of T cells in mycosis fungoides exhibiting marked epitheliotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 1989; 134: 955-60.
9. Sterry W, Mielke V, Konter U et al. Role of β1-integrins in epitheliotropism of malignant T cells. Am J Pathol 1992; 141: 855-60.
10. Nickoloff BJ, Griffiths CEM, Baadsguard O et al. Markedly diminished epidermal keratinocyte expression of the intercellular adhesion molecule-1 (ICAM-1) in Sézary syndrome. JAMA 1989; 261: 2217-21.
11. Jaspars EH, van der Linden JC, Scheffer GL et al. Monoclonal antibody 4C7 recognizes an endothelial basement membrane component that is selectively expressed in capillaries of lymphoid follicles. J Pathol 1993; 170: 121-8.
12. Cepek KL, Shaw SK, Parker CM et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 1994; 372: 190-3.
13. Eidelman S, Damsky CH, Wheelock MJ, Damjanov I. Expression of the cell-cell glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol 1989; 135: 101-10.
14. Domloge-Hultsch N, Gammon WR, Briggaman RA et al. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepiderrnal blistering skin disease. J Clin Invest 1992; 90: 1628-33.
15. Niesson CM, Hogervorst F, Jaspars LH et al. The α6β4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 1994; 211: 360-7.
16. Barker JNWN, Mitra RS, Griffiths CEM et al. Keratinocytes as mediators of inflammation. Lancet 1991; 337: 211-14.
17. Walsh LJ, Lavker RM, Murphy GF. Biology of disease: determinants of immune cell trafficking in the skin. Lab Invest 1990; 63: 592-600.
18. Chan BMC, Elices MJ, Murphy E, Hemler ME. Adhesion to vascular adhesion molecule 1 and fibronectin. Comparison of α4β1 (VLA 4) and α4β7 on the human B cell line JY. J Biol Chem 1992; 267: 8366-70.
19. Uccini S, Ruco LP, Monardo F et al. Molecular mechanisms involved in intraepithelial lymphocyte migration: a comparative study in skin and tonsil. J Pathol 1993; 169: 413-19.
20. Jaspars LH, Bonnet P, Bloemena E, Meijer CJLM. Extracellular matrix and β1 integrin expression in nodal and extranodal T-cell lymphomas. J Pathol 1996; 178: 36-43.